Larry represents leading global companies in complex business disputes and class actions, often with a cross-border component, in federal and state courts. He represents financial institutions, publicly traded companies, and individuals across a variety of industries, including technology, healthcare, and consumer products. Larry also represents clients in disputes out of court, including arbitration and mediation.

Larry was previously a judicial intern at the United States District Court for the Southern District of New York and an associate at Latham’s London office.

Larry’s experience includes advising:

  • The underwriters of MINISO’s IPO in a securities class action, resulting in complete dismissal (S.D.N.Y. 2024)
  • Sinovac Biotech Ltd. in:
    • Shareholder litigation concerning its 2018 PIPE transaction, resulting in dismissal with prejudice (D. Mass. 2023)
    • Shareholder litigation relating to the implementation of its poison pill, resulting in complete dismissal (Del. Ch. 2024)
  • A leading pool equipment manufacturer in a securities class action concerning channel stuffing allegations, resulting in full dismissal (D.N.J. 2024)
  • A Chinese internet security company in a securities class action concerning its take-private transaction, resulting in dismissal of over 99% of claimed damages (S.D.N.Y. 2023)
  • An exercise equipment company in defeating class certification and achieving a partial dismissal of claims in consumer class action alleging false advertising (S.D.N.Y. 2023)
  • Mallinckrodt Pharmaceuticals in reorganizing under chapter 11, following numerous contested matters and hotly contested confirmation hearing (Bankr. D. Del. 2022)

Bar Qualification

  • New York

Education

  • JD, Duke University School of Law, 2020
  • MA in Economic Law, Sciences Po Paris, 2020
  • BA in Political Science & Philosophy, Columbia University, 2017

Languages Spoken

  • English
  • Chinese (Mandarin)
  • French